Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00842764 · ClinicalTrials.gov registry record · NA
Minimally Invasive Holmium:YAG Laser Blepharoplasty
A NA study, sponsored by University of California, Irvine.
- Completed
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT00842764: Completed NA study, sponsored by University of California, Irvine.
NCT00842764 is a NA study that has completed, run by University of California, Irvine. The registered enrollment target is 7 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00842764, a NA study, has completed, sponsored by University of California, Irvine.
- COMPLETED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
The purpose of this research study is to is to evaluate the safety and effectiveness of the FDA approved Holmium:YAG laser for reducing lower eyelid bags.
Primary Outcome
Preoperative and postoperative (postoperative visits were at day 1, 1 week, 1 month, and 2 months) .photographs were evaluated by 6 surgeons on a 5-point Likert scale which 1 indicates worsening, 2 means unchanged, 3 is mild improvement, 4 is moderate improvement, and 5 indicates complete correction.
Interventions
- PROCEDURE Holmium: YAG laser
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2009-01 |
| Est. Completion | 2014-09 |
| Phase | NA |
What the finished NCT00842764 record still lists
NCT00842764 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Holmium: YAG laser is the first listed.
NCT00842764 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00842764 about?
NCT00842764 is a clinical study titled "Minimally Invasive Holmium:YAG Laser Blepharoplasty". The purpose of this research study is to is to evaluate the safety and effectiveness of the FDA approved Holmium:YAG laser for reducing lower eyelid bags.
What is the current status of trial NCT00842764?
This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2009-01. Estimated completion is 2014-09.
What interventions are being tested in trial NCT00842764?
The interventions under investigation include: Holmium: YAG laser (PROCEDURE).
Who is sponsoring clinical trial NCT00842764?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00842764's enrollment target sits among peer trials
7 1982nd of 2000 higher than 18 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia